These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

87 related articles for article (PubMed ID: 15751001)

  • 1. Synthesis and antiapoptotic activity of a novel analogue of the neutral sphingomyelinase inhibitor scyphostatin.
    Claus RA; Wüstholz A; Müller S; Bockmeyer CL; Riedel NH; Kinscherf R; Deigner HP
    Chembiochem; 2005 Apr; 6(4):726-37. PubMed ID: 15751001
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Synthesis and evaluation of three novel scyphostatin analogues as neutral sphingomyelinase inhibitors.
    Pitsinos EN; Wascholowski V; Karaliota S; Rigou C; Couladouros EA; Giannis A
    Chembiochem; 2003 Nov; 4(11):1223-5. PubMed ID: 14613115
    [No Abstract]   [Full Text] [Related]  

  • 3. Concise asymmetric total synthesis of scyphostatin, a potent inhibitor of neutral sphingomyelinase.
    Fujioka H; Sawama Y; Kotoku N; Ohnaka T; Okitsu T; Murata N; Kubo O; Li R; Kita Y
    Chemistry; 2007; 13(36):10225-38. PubMed ID: 17907134
    [TBL] [Abstract][Full Text] [Related]  

  • 4. LDL induces Saos2 osteoblasts death via Akt pathways responsive to a neutral sphingomyelinase inhibitor.
    Klein BY; Kerem Z; Rojansky N
    J Cell Biochem; 2006 Jun; 98(3):661-71. PubMed ID: 16440306
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Total synthesis of (+)-scyphostatin, a potent and specific inhibitor of neutral sphingomyelinase.
    Inoue M; Yokota W; Murugesh MG; Izuhara T; Katoh T
    Angew Chem Int Ed Engl; 2004 Aug; 43(32):4207-9. PubMed ID: 15307088
    [No Abstract]   [Full Text] [Related]  

  • 6. Influence of the scyphostatin side chain on the mode of inhibition of neutral sphingomyelinase.
    Wascholowski V; Giannis A; Pitsinos EN
    ChemMedChem; 2006 Jul; 1(7):718-21. PubMed ID: 16902925
    [No Abstract]   [Full Text] [Related]  

  • 7. Concise approach to the carbocyclic core of the naturally occurring sphingomyelinase inhibitor scyphostatin.
    Mehta G; Modugu NR
    J Org Chem; 2013 Apr; 78(7):3367-73. PubMed ID: 23442124
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Studies toward the total synthesis of scyphostatin: first entry to the highly functionalized cyclohexenone segment.
    Izuhara T; Katoh T
    Org Lett; 2001 May; 3(11):1653-6. PubMed ID: 11405678
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Synthesis of sphingomyelin sulfur analogue and its behavior toward sphingomyelinase.
    Hakogi T; Fujii S; Morita M; Ikeda K; Katsumura S
    Bioorg Med Chem Lett; 2005 Apr; 15(8):2141-4. PubMed ID: 15808485
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Synthesis and biochemical investigation of scyphostatin analogues as inhibitors of neutral sphingomyelinase.
    Arenz C; Gartner M; Wascholowski V; Giannis A
    Bioorg Med Chem; 2001 Nov; 9(11):2901-4. PubMed ID: 11597471
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Short and efficient route to the fully functionalized polar core of scyphostatin.
    Pitsinos EN; Cruz A
    Org Lett; 2005 May; 7(11):2245-8. PubMed ID: 15901180
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Potent inhibition of acid sphingomyelinase by phosphoinositide analogues.
    Roth AG; Redmer S; Arenz C
    Chembiochem; 2009 Sep; 10(14):2367-74. PubMed ID: 19688786
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Synthesis of a nitrogen analogue of sphingomyelin as a sphingomyelinase inhibitor.
    Hakogi T; Taichi M; Katsumura S
    Org Lett; 2003 Aug; 5(16):2801-4. PubMed ID: 12889878
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Stereoselective reactions of a (-)-quinic acid-derived enone: application to the synthesis of the core of scyphostatin.
    Murray LM; O'Brien P; Taylor RJ
    Org Lett; 2003 May; 5(11):1943-6. PubMed ID: 12762692
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Scyphostatin, a neutral sphingomyelinase inhibitor from a discomycete, Trichopeziza mollissima: taxonomy of the producing organism, fermentation, isolation, and physico-chemical properties.
    Nara F; Tanaka M; Hosoya T; Suzuki-Konagai K; Ogita T
    J Antibiot (Tokyo); 1999 Jun; 52(6):525-30. PubMed ID: 10470675
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Synthesis and evaluation of a difluoromethylene analogue of sphingomyelin as an inhibitor of sphingomyelinase.
    Yokomatsu T; Takechi H; Akiyama T; Shibuya S; Kominato T; Soeda S; Shimeno H
    Bioorg Med Chem Lett; 2001 May; 11(10):1277-80. PubMed ID: 11392536
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Development of carbohydrate-derived inhibitors of acid sphingomyelinase.
    Roth AG; Redmer S; Arenz C
    Bioorg Med Chem; 2010 Jan; 18(2):939-44. PubMed ID: 20005726
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Biological activities of scyphostatin, a neutral sphingomyelinase inhibitor from a discomycete, Trichopeziza mollissima.
    Nara F; Tanaka M; Masuda-Inoue S; Yamasato Y; Doi-Yoshioka H; Suzuki-Konagai K; Kumakura S; Ogita T
    J Antibiot (Tokyo); 1999 Jun; 52(6):531-5. PubMed ID: 10470676
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Entamoeba histolytica: molecular cloning and characterization of a novel neutral sphingomyelinase.
    Mendoza-Macías CL; Barrios-Ceballos MP; Anaya-Velázquez F; Nakada-Tsukui K; Nozaki T; Padilla-Vaca F
    Exp Parasitol; 2010 Jul; 125(3):279-85. PubMed ID: 20138872
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pertussis toxin promotes macrophage survival through inhibition of acid sphingomyelinase and activation of the phosphoinositide 3-kinase/protein kinase B pathway.
    Wang SW; Parhar K; Chiu KJ; Tran A; Gangoiti P; Kong J; Gonzalez M; Salh B; Duronio V; Steinbrecher UP; Gómez-Muñoz A
    Cell Signal; 2007 Aug; 19(8):1772-83. PubMed ID: 17521884
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.